Data on the effect of pro-fibrotic cytokine TGF-β on hepatic stellate cell autophagy

Paul G. Thomes, Elizabeth Brandon-Warner, Ting Li, Terrence M. Donohue, Laura W. Schrum

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Our data describe autophagic flux in primary rat hepatic stellate cells (rHSCs) treated with pro-fibrotic growth factor, transforming growth factor beta (TGF-β). An autophagy flux experiment determines the rate of synthesis and degradation of the autophagosome marker, LC3-II in the presence and absence of the lysosomal inhibitor bafilomcyin, which blocks LC3-II degradation in lysosomes. The effects of a test agent on LC3-II flux through the autophagic pathway is determined immunochemically by its relative amounts detected in lysates of cells treated with and without bafilomycin. This measurement helps to validate whether exposure to an agent affects the biogenesis or the degradation of autophagosomes during autophagy, a major macromolecular degrading mechanism in eukaryotic cells. (“Rev-erb Agonist and TGF-β Similarly Affect Autophagy but Differentially Regulate Hepatic Stellate Cell Fibrogenic Phenotype” (Thomes et al., in press) [1].

Original languageEnglish (US)
Pages (from-to)312-314
Number of pages3
JournalData in Brief
StatePublished - Feb 1 2017

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Data on the effect of pro-fibrotic cytokine TGF-β on hepatic stellate cell autophagy'. Together they form a unique fingerprint.

Cite this